1/46
AH2 exam 4
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
acquired immunity
immunity that develops during your life time
active immunity
develops in response to an infection or vaccination
natural active immunity
antibodies develop in response to an infection
artificial active immunity
antibodies develop in response to a vaccination
passive immunity
develops after you receive antibodies from someone or somewhere else
natural passive immunity
antibodies received from mother (i.e. breast milk)
artificial passive immunity
antibodies received from medicine
immune system locations
lymph nodes, tonsils, thymus, spleen (activate filter system and circulation), peyer’s patch, lymph vessels (activate filter system and circulation), bone marrow
WBCs
cells of immune system
made inside the bone marrow
travel through the body inside lymph vessels, which are in close contact w the blood stream
neutrophils
engulf and destroy
most plentiful and first to respond
monocytes (macrophages)
engulf, digest and destroy
the clean up crew
eosinophils
fight parasitic infections and allergic reactions
basophils
release histamine
inflammation and allergic response
lymphocytes
attack specific pathogens
viral and bacterial
B and T cells
plasma cells
produce antibodies
immune system affected by
CNS integrity
physical and emotional status
meds
diet
stress of illness, surgery or trauma
nursing assessment - background
assess: nutrition, recent infection, hx of autoimmune, cancer, chronic illness, surgery, meds and blood transfusions
weak immune system is unable to fight pathogens —> lacks sufficient WBC or antibodies
nursing assessment - symptoms
frequent infections w severe symptoms..
high fevers
chills
weakness
joint swelling
skin rashes
hypotension, anemia, hepatomegaly, NV, hematuria, resp distress, dysuria, polyuria, hematuria, inflammation, wound discharge, decreased cognition, headache
causes
autoimmune
lupus
RA
DM 1
infections
HIV —> AIDs
pneumonia
lymphoma
leukemia
sickle cell
immune cell deficiency
meds
immune suppressants
chemo
HIV
targets T cells
alters genetics
reshapes immune system
HIV causes
unprotected sex
sharing needles
needle stick
blood, semen, or vaginal fluids into open cuts or sores
blood transfusions w infected blood
passed from mother to baby during pregnancy, birth or breastfeeding
HIV stage 0
primary or acute HIV infection —> first detectable antibodies
1-2 weeks of initial infection
1-6 weeks of influenza like symptoms
temporary —> return to baseline
early symptoms of stage 0
fever and chills
sore throat, swollen lymph nodes, mouth ulcers
muscle fatigue and aches
NV, loss of appetite
joint pain
headaches and mood swings
pneumonia, cough w phlegm, SOB and chest pain
high HR and low BP
clamminess, rashes and blueness of the skin
women: changes in menstruation, lower belly pain and vaginal yeast infection
HIV stage 1
HIV asymptomatic (viral set point)
1-8 years
remain > 500 CD4
HIV stage 2
HIV symptomatic
CD4 200-499
chronic stage
coughing
breathing problems
weight loss
diarrhea
fatigue
rash
increased infections
cognitive changes
HIV stage 3
AIDS
lot of infections at one time
CD4 < 200
recurrent pneumonia
herpes
wasting syndrome
TB
AIDs main symptoms
central
encephalitis
meningitis
eyes
retinitis
lungs
pneuomocytitis pneumonia
TB (multiple organs)
tumors
skin
tumors
GI
esophagitis
chronic diarrhea
tumors
criteria for AIDS diagnosis
must have at least one
CDR < 200 and/or presence of an AIDS defining condition
cytomegalovirus retinitis (w loss of vision)
pneumocystis jiroveci pneumonia (PJP)
chronic intestinal cryptosporidosis
HIV related encephalopaty
mycobacterium TB
invasive cervical cancer
AIDS RF
unprotected sex
multiple sex partners
occupational exposures
perinatal exposure
blood transfusions
IVDU
older adults
fluid and electrolyte imbalance
decreased skin integrity
women: dry vagina, thin walls
dx
HIV-1/HIV-2 EIA —> repeatedly active —> HIV western blot
—> positive = report as HIV +
—> negative or indeterminate
HIV -2 EIA —> repeatedly reactive —> HIV-2 supplemental test
positive
negative
indeterminate
blood tests
CBC: neutropenia, thrombocytopenia, anemia
LFTs: altered liver function
infection w Hep B or C
lipid panels: hyperlipidemia common SE of meds
resistance tests: determine if HIV is becoming resistant to drugs
AIDS CM
immunologic
low WBC
opportunistic infection
lymphadenopathy
fatigue
integumentary
poor wound healing
skin lesions
night sweats
respiratory
cough
SOB
GI
diarrhea
weight loss
NV
CNS
confusion
dementia
headache
visual changes
personality changes
pain
seizures
opportunistic infections
protozoal infections
pneumocystis carini pneumonia
toxoplasmosis (encephalitis)
cryptosporidosis (GI)
fungal infections
candidasis - stomatitis, esophagitis, vaginal
bacterial infections
mycobacterium complex
TB
viral infections
cytomegalovirus
herpes
varicella-zoster virus
malignancies
Kaposi's sarcoma
Non-hodgkin's lymphoma
Hodgkin’s lymphoma
Invasive cervical carcinoma
AIDS dementia complex
cognitive, motor, and behavioral impairments in 70% AIDS clients
complications of AIDS
opportunistic infections
wasting syndrome
fluid and electrolyte imbalance
seizures from HIV encephalopathy
social isolation
pharm therapt
highly active antiretroviral therapy (HAART) —> use combination therapy
nucleoside reverse transcriptase (NRTIs) “nukes”
non-nucleoside reverse transcriptase (NNRTis) “non-nukes”
protease inhibitors (PIs)
integrase strand transfer inhibitors
fusion inhibitors
CCR5 antagonist
CD4 attachement inhibitor
issues w pharm therapy
does not kill the virus, only stops replication
drug resistance
drug resistance at time of HIV infection
selective drug resistance
med SE
hepatoroxicity
nephrotoxicity
osteopenia
increased risk of MI and cardiovascular disease
fat redistribution syndrome
metabolic alterations —> dyslipidemia, insulin resistance, facial wasting
prevention
HIV testing
treat all
end mother to child transmission
end discrimination
pre-exposure prophylaxis
post-exposure prophylaxis
test and treat STI
use condoms
increase funding
prevention for nurses
maintain standard precaution
hand hygiene, gloves, mask, eye shield, gown
do not recap needles and syringes
clean up spills of blood and bodily fluids using germicidal solution
consider all body fluids to be contaminated
avoid contaminating the outside of specimen containers
cleanse work surface areas w appropriate germicide
PREP
must be taken every day in order to be effective
people who use PREP include HIV negative people in monogamous relationship w HIV positive people, non-monogamous people in a high risk population and IVDU
when taken daily reduces chance of contracting HIV by 92%
SE: upset stomach, loss of appetite, headache
PEP
taken w/in 72 hours post exposure
contains 3 anti-HIV medications that must be taken daily for 28 days after exposure
SE: quite sick —> common cause for non-adherence
not 100% effective
nursing priorities
Transmission risk
Impaired skin integrity
fluid/electrolyte imbalance
Diarrhea
Risk for infection
Activity intolerance
Distributed thought process
Ineffective airway clearance
Pain
Imbalanced nutrition
Social isolation
Anticipatory grieving
Knowledge deficit
nursing goals
Keep viral load low
Maintain immune function (increased CD4 count)
adequate/good quality sleep
Access to medication
improve/maintain quality of life
Prevent opportunistic disease and new infections
reduce/prevent disability
Maintain medication and monitoring regimen
patient education
Good hand hygiene
Avoid crowds
Avoid raw and undercooked foods
Avoid cleaning cat litter
Keep home environment clean
Wash dishes in hot water
Transmission and infection control measures
Safe sex practices
PREP and PEP
Med admin and SE
Adherence to meds
Support systems
nursing interventions
Assess RF
Monitor I&O
Daily weights
Nutritional intake
Electrolytes
Assess skin
Pain management
Monitor vitals
Assess resp status
Assess neuro status
Prevent transmission